By Scientia Professor Anthony D Kelleher

Journal articles

Pinto AN; Hawke K; Castley A; Chibo D; Giallonardo FD; Cooper C; Sawleshwarkar S; Kelleher A; Dwyer DE, 2018, 'HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia', Future Virology, 13, pp. 575 - 584, http://dx.doi.org/10.2217/fvl-2018-0031

Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore RD; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE; Bas A; Cooper DA; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Pell C; Hoy J; Orth D; Pinto AN; Grulich A, 2018, 'Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study', Lancet HIV, 5, pp. e438 - e447, http://dx.doi.org/10.1016/S2352-3018(18)30132-2

Kelleher AD; Bamford L; Draganic D; Kaldor J, 2018, 'Obituary: David Cooper, transformative clinician scientist', CURRENT OPINION IN HIV AND AIDS, 13, pp. 289 - 290, http://dx.doi.org/10.1097/COH.0000000000000476

Worley MJ; Fei K; Lopez-Denman AJ; Kelleher AD; Kent SJ; Chung AW, 2018, 'Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC', Journal of Immunological Methods, 457, pp. 41 - 52, http://dx.doi.org/10.1016/j.jim.2018.03.007

Turville S; Kelleher A, 2018, 'Obituary: Remembering Professor David Cooper', Retrovirology, 15, pp. 40, http://dx.doi.org/10.1186/s12977-018-0418-1

Keen P; Gray RT; Telfer B; Guy R; Schmidt H; Whittaker B; Holden J; Holt M; Kelleher A; Wilson D; Callander D; Cooper DA; Prestage GP; Selvey C; Grulich A; Telfer B; Schmidt H-M; Holden J; Donovan B; Kaldor J, 2018, 'The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets', Journal of the International AIDS Society, 21, pp. e25109 - e25109, http://dx.doi.org/10.1002/jia2.25109

Pinto A; Di Giallonardo F; Keen P; Cooper C; Telfer B; Cooper D; Grulich A; Kelleher A, 2018, 'A10 Using the molecular epidemiology of HIV transmission in New South Wales to inform public health response: Assessing the representativeness of linked phylogenetic data', Virus Evolution, 4, http://dx.doi.org/10.1093/ve/vey010.009

MacIntyre CR; Costantino V; Chen X; Segelov E; Chughtai AA; Kelleher A; Kunasekaran M; Lane JM, 2018, 'Influence of population immunosuppression and past vaccination on smallpox reemergence', Emerging Infectious Diseases, 24, pp. 646 - 653, http://dx.doi.org/10.3201/eid2404.171233

Stirrup OT; Copas AJ; Phillips AN; Gill MJ; Geskus RB; Touloumi G; Young J; Bucher HC; Babiker AG; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Lutsar I; Chêne G; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte A; Luca A; Prins M; Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AM; Rosinska M; Muga R; Tor J; Olalla P; Cayla J; Moreno S; Monge S; Amo J; Romero J; Pérez-Hoyos S; Sönnerborg A; Bucher C; Günthard H; Scherrer A; Malyuta R; Murphy G; Porter K; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Price MA; Gilmour J; Kamali A; Karita E, 2018, 'Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion', HIV Medicine, 19, pp. 184 - 194, http://dx.doi.org/10.1111/hiv.12567

Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC; Sewell WA; Cowley M; Tangye SG; Kelleher AD; Phan TG, 2018, 'Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency', Journal of Clinical Immunology, 38, pp. 159 - 162, http://dx.doi.org/10.1007/s10875-018-0477-z

Jamil MS; McManus H; Callander D; Prestage G; Ali H; O’Connor CC; Chen M; McNulty AM; Knight V; Duck T; Keen P; Gray J; Medland N; Hellard M; Lewis DA; Grulich AE; Kaldor JM; Fairley CK; Donovan B; Guy RJ; Marshall L; Wilson D; Dickson B; Kong M; Smith LW; Cooper D; Selvey C; Holden J; Crooks L; Cooper C; Price K; de Wit J; Kelleher A; Mitchell J; Schmidt HM; Telfer B; Whittaker B; Cooper D; O'Connor C, 2018, 'Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health Clinics', AIDS and Behavior, 22, pp. 513 - 521, http://dx.doi.org/10.1007/s10461-017-2012-2

Tsukamoto T; Kariya R; Marks K; Hattori S; Ahlenstiel C; Symonds G; Okada S; Kelleher AD, 2018, 'Erratum: Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34R cells in HIV-1 infection (AIDS (2018) (2018) 32 (1737–1747) DOI: 10.1097/QAD.0000000000001882)', AIDS, 32, pp. 2857 - 2858, http://dx.doi.org/10.1097/01.aids.0000547984.16868.93

Soodla P; Simmons R; Huik K; Pauskar M; Jõgeda EL; Rajasaar H; Kallaste E; Maimets M; Avi R; Murphy G; Porter K; Lutsar I; Del Amo J; Meyer L; Bucher HC; Chêne G; Hamouda O; Pillay D; Prins M; Rosinska M; Sabin C; Touloumi G; Olson A; Cartier A; Fradette L; Walker S; Babiker A; De Luca A; Fisher M; Muga R; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Boufassa F; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Tor J; de Olalla PG; Cayla J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Sönnerborg A; Günthard H; Scherrer A; Malyuta R; Johnson A; Phillips A; Morrison C; Price MA; Giaquinto C; Grarup J; Kirk O; Bailey H; Volny Anne A; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Møller C; Rakhmanova A; Rockstroh J, 2018, 'HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay', HIV Medicine, 19, pp. 33 - 41, http://dx.doi.org/10.1111/hiv.12535

Philpot SP; Prestage G; Ellard J; Grulich AE; Bavinton BR; Kelleher A; Bloch M; Pell C; Zablotska-Manos I; Jin J; Cooper D; Wilson D; Triffitt K; Templeton D; McNulty A; Pinto A, 2018, 'How do gay serodiscordant couples in Sydney, Australia negotiate undetectable viral load for HIV prevention?', AIDS and Behavior, 22, pp. 3981 - 3990, http://dx.doi.org/10.1007/s10461-018-2247-6

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M; Bloch M; Cooper D, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, 19, pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532

Cook L; Munier CML; Seddiki N; van Bockel D; Ontiveros N; Hardy MY; Gillies JK; Levings MK; Reid HH; Petersen J; Rossjohn J; Anderson RP; Zaunders JJ; Tye-Din JA; Kelleher AD, 2017, 'Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease', Journal of Allergy and Clinical Immunology, 140, pp. 1592 - 1603.e8, http://dx.doi.org/10.1016/j.jaci.2017.02.015

Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus Nordwall J; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Han A, 2017, 'Circulating MIR-122 and MIR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals', Scientific Reports, 7, pp. 10934, http://dx.doi.org/10.1038/s41598-017-11405-8

McLaren PJ; Pulit SL; Gurdasani D; Bartha I; Shea PR; Pomilla C; Gupta N; Gkrania-Klotsas E; Young EH; Bannert N; Del Amo J; Gill MJ; Gilmour J; Kellam P; Kelleher AD; Sönnerborg A; Zangerle R; Post FA; Fisher M; Haas DW; Walker BD; Porter K; Goldstein DB; Sandhu MS; De Bakker PIW; Fellay J, 2017, 'Evaluating the impact of functional genetic variation on HIV-1 Control', Journal of Infectious Diseases, 216, pp. 1063 - 1069, http://dx.doi.org/10.1093/infdis/jix470

Murray JM; Zaunders J; Emery S; Cooper DA; Hey-Nguyen WJ; Koelsch KK; Kelleher AD, 2017, 'HIV dynamics linked to memory CD4+ T cell homeostasis', Plos One, 12, pp. e0186101, http://dx.doi.org/10.1371/journal.pone.0186101

Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wasik TJ; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Kücherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte AD; De Luca A; Prins M; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Muga R; Tor J; de Olalla PG; Cayla J; del Amo J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Bucher HC; Rickenbach M; Francioli P; Malyuta R; Murphy G; Sabin C; Porter K; Johnson A; Phillips A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Gibb D; Grarup J; Kirk O; Kjaer J; Panteleev A; Reiss P; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; De Wolf F; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Anne AV, 2017, 'HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review', AIDS Reviews, 19, pp. 219 - 230

Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig KJ; Beard MR; Suzuki K; Kelleher AD; Hertzog P; Cunningham AL, 2017, 'Mechanism of interferon-stimulated gene induction in HIV-1- infected macrophages', Journal of Virology, 91, http://dx.doi.org/10.1128/JVI.00744-17

Madhavi V; Wines BD; Amin J; Emery S; Lopez E; Kelleher A; Center RJ; Mark Hogarth P; Chung AW; Kent SJ; Stratov I, 2017, 'HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV', Journal of Virology, 91, pp. 10.1128/jvi.00700 - 10.1128/jvi.00717, http://dx.doi.org/10.1128/JVI.00700-17

Phetsouphanh C; Xu Y; Munier ML; Zaunders JJ; Kelleher AD, 2017, 'Single-cell profiling of lineage determining transcription factors in antigen-specific CD4+ T cells reveals unexpected complexity in recall responses during immune reconstitution', Immunology and Cell Biology, 95, pp. 640 - 646, http://dx.doi.org/10.1038/icb.2017.28

Madhavi V; Kulkarni A; Shete A; Lee WS; McLean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ, 2017, 'Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts', Journal of Acquired Immune Deficiency Syndromes, 75, pp. 345 - 353, http://dx.doi.org/10.1097/QAI.0000000000001380

Koelsch KK; Rasmussen TA; Hey-Nguyen WJ; Pearson C; Xu Y; Bailey M; Marks KH; Sasson SC; Taylor MS; Tantau R; Obeid S; Milner B; Morrissey O; Pinto AN; Suzuki K; Busch MP; Keating SM; Kaiser P; Yukl S; Wong JK; Hiener BM; Palmer S; Zaunders J; Post JJ; Chan DJ; Avery S; Milliken ST; Kelleher AD; Lewin SR; Cooper DA; Cooper D, 2017, 'Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals', Journal of Acquired Immune Deficiency Syndromes, 75, pp. 328 - 337, http://dx.doi.org/10.1097/QAI.0000000000001381

Hey-Nguyen WJ; Xu Y; Pearson CF; Bailey M; Suzuki K; Tantau R; Obeid S; Milner B; Field A; Carr A; Bloch M; Cooper DA; Kelleher AD; Zaunders JJ; Koelsch KK, 2017, 'Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes during Antiretroviral Therapy', AIDS Research and Human Retroviruses, 33, pp. 648 - 657, http://dx.doi.org/10.1089/aid.2016.0171

Zaunders J; Xu Y; Kent SJ; Koelsch KK; Kelleher AD, 2017, 'Divergent expression of CXCR5 and CCR5 on CD4+ T cells and the paradoxical accumulation of T follicular helper cells during HIV infection', Frontiers in Immunology, 8, pp. 495, http://dx.doi.org/10.3389/fimmu.2017.00495

Castley A; Sawleshwarkar S; Varma R; Herring B; Thapa K; Dwyer D; Chibo D; Nguyen N; Hawke K; Ratcliff R; Garsia R; Kelleher A; Nolan D, 2017, 'A national study of the molecular epidemiology of HIV-1 in', Plos One, 12, pp. e0170601, http://dx.doi.org/10.1371/journal.pone.0170601

Kent SJ; Kelleher AD, 2017, 'Expanding role for type i Interferons in restricting HIV growth', Immunology and Cell Biology, 95, pp. 417 - 418, http://dx.doi.org/10.1038/icb.2017.15

Xu Y; Phetsouphanh C; Suzuki K; Aggrawal A; Graff-Dubois S; Roche M; Bailey M; Alcantara S; Cashin K; Sivasubramaniam R; Koelsch KK; Autran B; Harvey R; Gorry PR; Moris A; Cooper DA; Turville S; Kent SJ; Kelleher AD; Zaunders J; Aggarwal A, 2017, 'HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells', Frontiers in Immunology, 8, pp. 376, http://dx.doi.org/10.3389/fimmu.2017.00376

Murray JM; Maher S; Mota T; Suzuki K; Kelleher AD; Center RJ; Purcell D, 2017, 'Differentiating founder and chronic HIV envelope sequences', Plos One, 12, pp. e0171572, http://dx.doi.org/10.1371/journal.pone.0171572

Juno JA; Bockel DV; Kent SJ; Kelleher AD; Zaunders JJ; Munier CML, 2017, 'Cytotoxic CD4 T cells-friend or foe during viral infection?', Frontiers in Immunology, 8, http://dx.doi.org/10.3389/fimmu.2017.00019

Zaunders J; Howe A; Ledger S; Kelleher A; Murray J; Symonds G, 2017, '23 Knockdown of CCR5 expression in antigen-specific cytotoxic CD4 T cells', Journal of Virus Eradication, 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30728-7

Klemm V; Mitchell J; Cortez-Jugo C; Cavalieri F; Symonds G; Caruso F; Kelleher AD; Ahlenstiel C, 2016, 'Achieving HIV-1 control through RNA-directed gene regulation', Genes, 7, http://dx.doi.org/10.3390/genes7120119

Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576

Tjiam MC; Sariputra L; Armitage JD; Taylor JPA; Kelleher AD; Tan DBA; Lee S; Fernandez S; French MA, 2016, 'Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24', AIDS, 30, pp. 2757 - 2765, http://dx.doi.org/10.1097/QAD.0000000000001242

Zaunders J; Danta M; Bailey M; Mak G; Marks K; Seddiki N; Xu Y; Templeton DJ; Cooper DA; Boyd MA; Kelleher AD; Koelsch KK, 2016, 'CD4+ T follicular helper and IgA+ B cell numbers in gut biopsies from HIV-infected subjects on antiretroviral therapy are similar to HIV-uninfected individuals', Frontiers in Immunology, 7, pp. 438, http://dx.doi.org/10.3389/fimmu.2016.00438

Munier CML; van Bockel D; Bailey M; Ip S; Xu Y; Alcantara S; Liu SM; Denyer G; Kaplan W; Suzuki K; Croft N; Purcell A; Tscharke D; Cooper DA; Kent SJ; Zaunders JJ; Kelleher AD, 2016, 'The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype', Vaccine, 34, pp. 5251 - 5261, http://dx.doi.org/10.1016/j.vaccine.2016.09.009

Cook L; Zaunders JJ; Kelleher AD, 2016, 'Comment on "A cytokine- independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD41 T cells in blood', Journal of Immunology, 197, pp. 2557 - 2558, http://dx.doi.org/10.4049/jimmunol.1601311

Mak G; Zaunders JJ; Bailey M; Seddiki N; Xu Y; Cooper D; Boyd M; Kelleher A; Danta M; Koelsch KK, 2016, 'Gut integrity, CD4+T follicular helper cells, and IgA plus B cells in gastrointestinal-associated lymphoid tissue following ART', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2016, 'Erratum: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission (PLoS Pathogens (2015) 11:7 (e1005000) DOI: 10.1371/journal.ppat.1005000)', PLoS Pathogens, 12, pp. e1005745, http://dx.doi.org/10.1371/journal.ppat.1005745

Pinkevych M; Kent SJ; Tolstrup M; Lewin SR; Cooper DA; Søgaard OS; Rasmussen TA; Kelleher AD; Cromer D; Davenport MP, 2016, 'Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days', Plos Pathogens, 12, pp. e1005740, http://dx.doi.org/10.1371/journal.ppat.1005740

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S; Cooper D; Tu E; Silk D, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study', Clinical Infectious Diseases, 63, pp. 122 - 132, http://dx.doi.org/10.1093/cid/ciw207

Li J; Hardy K; Phetsouphanh C; Tu WJ; Sutcliffe EL; McCuaig R; Sutton CR; Zafar A; Mee Ling Munier C; Zaunders JJ; Xu Y; Theodoratos A; Tan A; SiewLim P; Knaute T; Masch A; Zerweck J; Brezar V; Milburn PJ; Dunn J; Casarotto MG; Turner SJ; Seddiki N; Kelleher AD; Rao S; Munier ML, 2016, 'Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4+T cells through p65 and H2B phosphorylation', Journal of Cell Science, 129, pp. 2448 - 2461, http://dx.doi.org/10.1242/jcs.181248

Pantazis N; Touloumi G; Meyer L; Olson A; Costagliola D; Kelleher AD; Lutsar I; Chaix ML; Fisher M; Moreno S; Porter K, 2016, 'The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment', AIDS, 30, pp. 879 - 888, http://dx.doi.org/10.1097/QAD.0000000000000991

McAllery SA; Ahlenstiel CL; Suzuki K; Symonds GP; Kelleher AD; Turville SG, 2016, 'The feasibility of incorporating Vpx into lentiviral gene therapy vectors', Molecular Therapy Methods and Clinical Development, 3, pp. 16066, http://dx.doi.org/10.1038/mtm.2016.66

Appay V; Kelleher AD, 2016, 'Immune activation and immune aging in HIV infection', Current Opinion in HIV and AIDS, 11, pp. 242 - 249, http://dx.doi.org/10.1097/COH.0000000000000240

Zaunders J; Jing J; Leipold M; Maecker H; Kelleher AD; Koch I, 2016, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms', Cytometry Part A, 89, pp. 44 - 58, http://dx.doi.org/10.1002/cyto.a.22704

, 2016, 'Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa.', J Int AIDS Soc, 19, pp. 21264, http://dx.doi.org/10.7448/IAS.19.6.21264

Pantazis N; Touloumi G; Meyer L; Olson A; Costagliola D; Kelleher AD; Lutsar I; Chaix ML; Fisher M; Moreno S; Porter K, 2015, 'The impact of transient cART in early HIV infection on viral suppression and immunologic response in later treatment', AIDS, http://dx.doi.org/10.1097/QAD.0000000000000991

Back to profile page